Biosynthetic engineering of polyene macrolides for generation of improved antifungal and antiparasitic agents

Files in This Item:
File Description SizeFormat 
CTMCTextWithEmbeddedFigures.pdf309.71 kBAdobe PDFDownload
Title: Biosynthetic engineering of polyene macrolides for generation of improved antifungal and antiparasitic agents
Authors: Caffrey, Patrick
Aparicio, Jesus F.
Malpartid, Francisco
Zotchev, Sergey B.
Permanent link:
Date: 2008
Abstract: Polyene macrolides are potent antifungal agents that are also active against parasites, enveloped viruses and prion diseases. They are medically important as antifungal antibiotics but their therapeutic use is limited by serious side effects. In recent years there has been considerable progress in genetic analysis and manipulation of the streptomycetes that produce nystatin, amphotericin B, candicidin, pimaricin and rimocidin/CE-108-related polyenes. This has led to engineered biosynthesis of several new polyenes that are not easily obtained as semi-synthetic derivatives. This review summarises recent advances made since the subject was last reviewed in 2003. Polyene biosynthesis generally involves assembly and cyclisation of a polyketide chain, followed by oxidative modifications and glycosylation of the macrolactone ring. New derivatives have been obtained by engineering both early and late stages of polyene biosynthetic pathways. These compounds have allowed more detailed investigations of structure-activity relationships and some are likely to show improvements in therapeutic index. The biosynthetic approach is already yielding sufficient material for testing the toxicity and activity of new compounds, thus opening possibilities for discovery of leads for development of effective and safe antifungal and antiparasitic agents.
Type of material: Journal Article
Publisher: Bentham Science Publishers
Journal: Current Topics in Medicinal Chemistry
Volume: 8
Issue: 8
Start page: 639
End page: 653
Keywords: PolyenesPolyketidesEngineered biosynthesisAntifungalsAntiparasitic drugs
DOI: 10.2174/156802608784221479
Language: en
Status of Item: Peer reviewed
Appears in Collections:Biomolecular and Biomedical Science Research Collection
CSCB Research Collection

Show full item record

Citations 5

Last Week
Last month
checked on Oct 20, 2018

Download(s) 50

checked on May 25, 2018

Google ScholarTM



This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.